Market Overview

Hearing BTIG Desk Has Highlighted Zika Not Listed On INTERCEPT's FDA Label, Prevents Co From Making Zika Reduction Claims To Blood Centers/Hospitals

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for CERS

DateFirmActionFromTo
Apr 2016BTIG ResearchMaintainsBuy
Dec 2015WedbushDowngradesOutperformNeutral
Apr 2015BTIG ResearchInitiates Coverage onBuy

View More Analyst Ratings for CERS
View the Latest Analyst Ratings

Posted-In: Analyst Color News Rumors Price Target Reiteration Analyst Ratings

 

Related Articles (CERS)